These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16360341)

  • 1. A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.
    Olivier A; Jeanson-Leh L; Bouma G; Compagno D; Blondeau J; Seye K; Charrier S; Burns S; Thrasher AJ; Danos O; Vainchenker W; Galy A
    Mol Ther; 2006 Apr; 13(4):729-37. PubMed ID: 16360341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
    Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
    Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells.
    Calle Y; Chou HC; Thrasher AJ; Jones GE
    J Pathol; 2004 Nov; 204(4):460-9. PubMed ID: 15495215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation of DC is associated with changes in motile characteristics and adherence.
    Burns S; Hardy SJ; Buddle J; Yong KL; Jones GE; Thrasher AJ
    Cell Motil Cytoskeleton; 2004 Feb; 57(2):118-32. PubMed ID: 14691951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro.
    Dewey RA; Avedillo Díez I; Ballmaier M; Filipovich A; Greil J; Güngör T; Happel C; Maschan A; Noyan F; Pannicke U; Schwarz K; Snapper S; Welte K; Klein C
    Exp Hematol; 2006 Sep; 34(9):1161-9. PubMed ID: 16939809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wiskott-Aldrich syndrome.
    Ochs HD; Thrasher AJ
    J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Boztug K; Dewey RA; Klein C
    Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
    Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
    Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.
    Candotti F; Facchetti F; Blanzuoli L; Stewart DM; Nelson DL; Blaese RM
    Gene Ther; 1999 Jun; 6(6):1170-4. PubMed ID: 10455421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences.
    Martín F; Toscano MG; Blundell M; Frecha C; Srivastava GK; Santamaría M; Thrasher AJ; Molina IJ
    Gene Ther; 2005 Apr; 12(8):715-23. PubMed ID: 15750617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts.
    Mizutani K; Miki H; He H; Maruta H; Takenawa T
    Cancer Res; 2002 Feb; 62(3):669-74. PubMed ID: 11830518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein.
    Toscano MG; Frecha C; Benabdellah K; Cobo M; Blundell M; Thrasher AJ; García-Olivares E; Molina IJ; Martin F
    Hum Gene Ther; 2008 Feb; 19(2):179-97. PubMed ID: 18240968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic lineage cell-specific protein 1 functions in concert with the Wiskott-Aldrich syndrome protein to promote podosome array organization and chemotaxis in dendritic cells.
    Dehring DA; Clarke F; Ricart BG; Huang Y; Gomez TS; Williamson EK; Hammer DA; Billadeau DD; Argon Y; Burkhardt JK
    J Immunol; 2011 Apr; 186(8):4805-18. PubMed ID: 21398607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cells.
    Andreu N; Aran JM; Fillat C
    Int J Mol Med; 2007 Oct; 20(4):445-50. PubMed ID: 17786274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of TccP-mediated N-WASP activation during enterohaemorrhagic Escherichia coli infection.
    Garmendia J; Carlier MF; Egile C; Didry D; Frankel G
    Cell Microbiol; 2006 Sep; 8(9):1444-55. PubMed ID: 16922863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of WASP and Scar1/WAVE1 actin-associated proteins is differentially modulated during differentiation of HL-60 cells.
    Launay S; Brown G; Machesky LM
    Cell Motil Cytoskeleton; 2003 Apr; 54(4):274-85. PubMed ID: 12601690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets.
    Alves MP; Neuhaus V; Guzylack-Piriou L; Ruggli N; McCullough KC; Summerfield A
    Gene Ther; 2007 May; 14(10):836-44. PubMed ID: 17330086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
    Avedillo Díez I; Zychlinski D; Coci EG; Galla M; Modlich U; Dewey RA; Schwarzer A; Maetzig T; Mpofu N; Jaeckel E; Boztug K; Baum C; Klein C; Schambach A
    Mol Pharm; 2011 Oct; 8(5):1525-37. PubMed ID: 21851067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.